Evoxac
NDC 16590-859
Product Information
Evoxac is a NDA-approved product labeled by Stat Rx Usa Llc. This medication is used to treat symptoms of dry mouth due to a certain immune disease (Sjogren's syndrome). It is supplied as a white product. This product entry covers the primary NDC 16590-859 and 4 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
EVOXAC;30;MG
Code Structure Chart
Product Details
What is NDC 16590-859?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CEVIMELINE HYDROCHLORIDE (UNII: P81Q6V85NP)
- CEVIMELINE (UNII: K9V0CDQ56E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 261361 - Evoxac 30 MG Oral Capsule
- RxCUI: 261361 - cevimeline hydrochloride 30 MG Oral Capsule [Evoxac]
- RxCUI: 309140 - cevimeline HCl 30 MG Oral Capsule
- RxCUI: 309140 - cevimeline hydrochloride 30 MG Oral Capsule
* Please review the full disclaimer at the bottom of this page.